52-week efficacy and safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-positive chronic hepatitis B (Q34579911)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | 52-week efficacy and safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-positive chronic hepatitis B |
scientific article |
Statements
1 reference
52-week efficacy and safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-positive chronic hepatitis B (English)
1 reference
Stefan Zeuzem
1 reference
Tawesak Tanwandee
1 reference
Teerha Piratvisuth
1 reference
Wattana Sukeepaisarnjaroen
1 reference
Henry L Y Chan
1 reference
Mário G Pessôa
1 reference
Eduardo Fassio
1 reference
Suzane K Ono
1 reference
Fernando Bessone
1 reference
Jorge Daruich
1 reference
Hugo Cheinquer
1 reference
Rashidkhan Pathan
1 reference
Yuhong Dong
1 reference
Aldo Trylesinski
1 reference
4 February 2013
1 reference
1 reference
8
1 reference
2
1 reference
e54279
1 reference
4 February 2013
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference